期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

晚期糖基化终末产物与腹膜透析相关性腹膜硬化 被引量：1

下载PDF
导出
摘要 腹膜透析(PD)相关性腹膜硬化是腹透的严重并发症之一,其中多数患者因此而终止PD治疗;它不仅影响PD治疗的效果,而且严重威胁患者的生命。因此,有关PD相关性腹膜硬化的发病机理和防治的研究一直是肾脏学者的重要课题。一个近年来很受重视的研究方向是晚期糖基化终末产物(Advanced Glycation End- products,AGEs)。本文拟对其在PD相关性腹膜硬化中倍受关注的几个方面作一简要综述。
作者 田莉
机构地区 天津医科大学第二医院肾内科
出处 《透析与人工器官》 2005年第1期8-15,共8页 Chinese Journal of Dialysis and Artificial Organs
关键词 晚期糖基化终末产物 腹膜硬化 透析相关性 PD治疗 严重并发症 腹膜透析 发病机理 End 患者
分类号 R977 [医药卫生—药品] R459.5 [医药卫生—治疗学]
  • 相关文献

参考文献45

  • 1Bierhaus A, Hofmann MA, Ziegler R, et al.AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. Ⅰ. The AGE concept. Cardiovasc Res. 1998; 37(3): 586-600.
  • 2Nagai R, Hayashi CM, Xia L, et al. Identification in Human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde- modified proteins. J. Biol. Chem. 2002,277(50): 48905-48912.
  • 3Sensi M, Pricci F, Andreani D, et al. Advanced nonenzymatic glycation endproducts (AGE). Diabetes Res. , 1991,16 (1): 1-9.
  • 4Thome J, Munch G, Nuller R, et al. Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease. Life Sci. ,1996,59(8): 679-85.
  • 5Swamy-Mruthinti s, Green K, Abraham EC, et al. Inhibition of cataracts in moderately diabetes rats by ainoguanidine. Exp. Eye. Res. , 1996, 62(5): 505-10.
  • 6Bucala R, Makita Z, K0schinsky T, et al. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad Sci. LISA. , 1993,90(14): 6434-8.
  • 7Bueala R, Makita Z, Vega G, et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad Sci.USA. ,1994,91(20): 9441-5.
  • 8Lee AT, Cerami A, et al. Elevated glucose 6-phosphate levels are associated with plasmid mutations in vivo. Proc. Natl. Acad. Sci. USA. 1987,84(23):8311-4.
  • 9Vlassara H, Bucala R, Striker L, et al.Pathogenic effects of advanced glycosylation:biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. , 1994, 70:138-151.
  • 10Li YM, Mitsuhashi T, Wojciechowicz D, et al.Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and P90 to 80K-H membrance proteins. Proc. Natl. Acad Sci. USA. ,1996,93 (20) : 11047- 52.

二级参考文献6

共引文献18

同被引文献26

  • 1邢静萍,陈楠.Smad与肾纤维化[J].中国中西医结合肾病杂志,2005,6(5):302-304. 被引量：15
  • 2Lee HB, Song JS, Ha H. Mechanisms of epithelial mesenchymal transition in human peritoneal mesothelial cells. Korean J Nephro1,2006, 25 (Suppl 1) : S97.
  • 3Kihm LP, Wibisono D, Muller - Krebs et al. SRAGE expression in the human peritoneal membrane. Nephrol Dial Transplant. 2008 Oct; 23(10) :3302 -3306..
  • 4An S, De Vriese, Ronald G, et al, Myofibroblast Transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant,2006,21:2549 - 2555.
  • 5Dijke P, Hill CS. New insights into TGF - beta - Smad signaling trends. Biochem Sci, 2004,29:265 -273.
  • 6Szeto CC,Lai KB, Chow KM, et al. Differential effects of transfor ming growth factor2beta on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell. Nephron Exp Nephrol, 2005, 99 (4) : e952-e104.
  • 7Peinado H ,Quintanilla M, Cano A. Transforming growth faetorβ - 1 induces snail transcription factor in epithelial cell lines :mechanisms for epithelial mesenchymal transitions. J Biol Chem, 2003 ,278 (23) :21113- 23.
  • 8Liu Y. Epithelial to mesenehymal transition in renal fibrogenesis: Pathologic signify - eance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol, 2004,15( 1 ) :1 - 12.
  • 9Regina Vargha, Michaela Endemann, Klaus Kratochwill. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown. Nephrol Dial Transplant (2006) 21 : 2943 - 2947.
  • 10Qiang Yao, Krzysztof Pawlaczyk, Ernesto Rodriguez Ayala,et al. The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephml,2008, 109 :e71 - e78.

引证文献1

透析与人工器官
2005年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部